NORDEN GROUP LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1990699 PROVO, UT

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$3,938,775

-$283,717 QoQ

Shares Held

31,176

+2.9% QoQ

Ownership

0.003%

of shares outstanding

% of Portfolio

0.40%

of 13F equity value

Holder Rank

#639

of 2,266 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORDEN GROUP LLC holds $53,447,474 across 12 Drug Manufacturers - General names. GILD ranks #6 (7.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	223,889	$12,900,484
2	LLY	ELI LILLY & Co	7,327	$8,788,224
3	JNJ	Johnson & Johnson	34,402	$8,737,075
4	MRK	Merck & Co., Inc.	45,186	$5,806,401
5	ABBV	AbbVie Inc.	19,879	$5,002,351
6	GILD	Gilead Sciences, Inc. This page	31,176	$3,938,775
7	AMGN	Amgen Inc	10,471	$3,791,758
8	NVO	Novo Nordisk A S	38,789	$1,859,544

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,938,775	31,176	+2.9%	Shares	Sole	2026-07-29
2026-03-31	$4,222,492	30,297	-2.4%	Shares	Sole	2026-04-15
2025-12-31	$3,810,708	31,047	+1.4%	Shares	Sole	2026-01-13
2025-09-30	$3,397,599	30,609	-58.5%	Shares	Sole	2025-10-15
2025-06-30	$8,178,990	73,771	+172.8%	Shares	Sole	2025-07-15
2025-03-31	$3,030,504	27,046	+3.6%	Shares	Sole	2025-05-07
2024-12-31	$2,411,226	26,104	+1.3%	Shares	Sole	2025-02-05
2024-09-30	$2,159,634	25,759	+154.9%	Shares	Sole	2024-10-17
2024-06-30	$693,372	10,106	-16.3%	Shares	Sole	2024-08-06
2024-03-31	$884,786	12,079	-55.5%	Shares	Sole	2024-04-30
2023-12-31	$2,200,474	27,163	+240.1%	Shares	Sole	2024-02-05
2023-09-30	$598,470	7,986	—	Shares	Other	2023-11-06
No filing history on record for this holder in this stock.